Insider · CIK 0001830326

Sanchez Ramiro

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001830326

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-23	RAPPRapport Therapeutics, Inc.P Purchase	Director	PPurchase	+3,600 sh	$27.35	+$98.5K	3,600
2026-06-10	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.2K sh	—	—	15,200
2026-05-12	ANROAlto Neuroscience, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11K sh	—	—	10,958
2026-01-02	ANROAlto Neuroscience, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,806 sh	$11.82	+$45K	3,806
2025-08-12	ANROAlto Neuroscience, Inc. · Stock Option (right to buy)A Award	Director	AAward	+30.6K sh	—	—	30,574
2025-08-12	ANROAlto Neuroscience, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,928 sh	$2.21	+$8,680.88	3,928
2025-06-17	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.9K sh	—	—	10,925
2024-11-07	RAPPRapport Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+29.8K sh	—	—	29,756
2024-08-01	Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−14.7K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−1.39M sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsD Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−87.6K sh	—	—	0
2024-01-19	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsA Award	Chief Medical Officer	AAward	+87.6K sh	—	—	87,573
2023-12-26	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+10K sh	$3.50	+$35K	24,673
2023-12-26	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Medical Officer	SSale	−10K sh	$42.47	−$425K	14,673
2023-12-26	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−10K sh	—	—	538,435
2023-12-20	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Medical Officer	SSale	−10.2K sh	$41.42	−$421K	14,673
2023-12-19	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+24.8K sh	—	—	24,825
2023-12-19	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsM Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−24.8K sh	—	—	0
2023-12-15	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+7,500 sh	$9.88	+$74.1K	7,500
2023-12-15	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Medical Officer	SSale	−7,500 sh	$41.39	−$310K	0
2023-12-15	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−7,500 sh	—	—	123,390
2023-12-07	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	+10K sh	$3.50	+$35K	10,000
2023-12-07	Cerevel Therapeutics Holdings, Inc.S Sale	Chief Medical Officer	SSale	−10K sh	$41.37	−$414K	0
2023-12-07	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Medical Officer	MExercise/Conversion	−10K sh	—	—	548,435
2023-02-06	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+97.7K sh	—	—	97,691
2023-02-06	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsA Award	Chief Medical Officer	AAward	+24.8K sh	—	—	24,825
2022-02-09	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+169K sh	—	—	168,856
2021-02-03	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+279K sh	—	—	278,637
2020-10-28	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+131K sh	—	—	130,890

Recent filings

Accepted (ET)
Oct 234
Sanchez Ramiro0001193125-26-430397
SEC(opens sec.gov)
Jun 104
Sanchez Ramiro0001193125-26-266080
SEC(opens sec.gov)
May 144
Sanchez Ramiro0001830326-26-000005
SEC(opens sec.gov)
Jan 64
Sanchez Ramiro0001830326-26-000002
SEC(opens sec.gov)
Aug 144
Sanchez Ramiro0001999480-25-000081
SEC(opens sec.gov)
Jun 184
Sanchez Ramiro0000950170-25-087904
SEC(opens sec.gov)
Nov 74
Sanchez Ramiro0000950170-24-123600
SEC(opens sec.gov)
Aug 54
Sanchez Ramiro0000950170-24-090861
SEC(opens sec.gov)
Jan 234
Sanchez Ramiro0000950170-24-006671
SEC(opens sec.gov)
Dec 284
Sanchez Ramiro0000950170-23-073591
SEC(opens sec.gov)
Dec 214
Sanchez Ramiro0000950170-23-072370
SEC(opens sec.gov)
Dec 194
Sanchez Ramiro0000950170-23-071490
SEC(opens sec.gov)

Companies

Address

RAPPORT THERAPEUTICS, INC. 99 HIGH STREET, SUITE 2100

BOSTON, MA, 02110